pubmed-article:19885619 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19885619 | lifeskim:mentions | umls-concept:C0040669 | lld:lifeskim |
pubmed-article:19885619 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:19885619 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
pubmed-article:19885619 | lifeskim:mentions | umls-concept:C0025914 | lld:lifeskim |
pubmed-article:19885619 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
pubmed-article:19885619 | lifeskim:mentions | umls-concept:C0205282 | lld:lifeskim |
pubmed-article:19885619 | lifeskim:mentions | umls-concept:C0031437 | lld:lifeskim |
pubmed-article:19885619 | lifeskim:mentions | umls-concept:C1414059 | lld:lifeskim |
pubmed-article:19885619 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
pubmed-article:19885619 | lifeskim:mentions | umls-concept:C0205360 | lld:lifeskim |
pubmed-article:19885619 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:19885619 | pubmed:dateCreated | 2009-11-3 | lld:pubmed |
pubmed-article:19885619 | pubmed:abstractText | The reduced expression in immortalized cells (REIC)/Dickkopf (Dkk)-3, a member of the Dkk gene family, is a tumor suppressor in a broad range of cancers. REIC/Dkk-3 transfected stable clones of mouse prostate cancer RM9 cells (RM9-REIC) and the empty vector-transfected control clone cells (RM9-EV) were established. Clones were used to evaluate the anti-cancer effects and a proteomics analysis of REIC/Dkk-3 continuous expression was performed. The RM9-REIC cells show a feeble appearance and the cell membrane shows irregular buds known as blebs. In vitro cell proliferation was significantly suppressed in RM9-REIC clones in comparison to the control. The apoptosis assay was done under standard culture conditions and RM9-REIC showed a higher incidence of apoptosis. The RM9-EV and RM9-REIC cells were orthotopically implanted into a C57BL/6 mouse prostate. After 2 weeks, the tumor growth was significantly inhibited in RM9-REIC cells in comparison to the control. Two-dimensional gel electrophoresis was used to examine the modification of protein expression by the gene transfection. The analysis with mass spectrometry disclosed that expression of peroxiredoxin-1, GST-P1, transgelin-2, MRP-L12, ARD, GRP78 and Sorcin were increased and eEF1A-1 and cyclophilin-40 protein were decreased in RM9-REIC cells. Therefore, REIC/Dkk-3 stable transfectants show a reduction of malignancy in mouse prostate cancer RM9 cells in vitro and in vivo. The result of the proteomics analysis might provide important clues to clarify the anti-cancer molecular mechanism of REIC/Dkk-3 gene transfer. | lld:pubmed |
pubmed-article:19885619 | pubmed:language | eng | lld:pubmed |
pubmed-article:19885619 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19885619 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19885619 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19885619 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19885619 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19885619 | pubmed:month | Dec | lld:pubmed |
pubmed-article:19885619 | pubmed:issn | 1791-244X | lld:pubmed |
pubmed-article:19885619 | pubmed:author | pubmed-author:HuangPengP | lld:pubmed |
pubmed-article:19885619 | pubmed:author | pubmed-author:ChenJieJ | lld:pubmed |
pubmed-article:19885619 | pubmed:author | pubmed-author:WatanabeMasam... | lld:pubmed |
pubmed-article:19885619 | pubmed:author | pubmed-author:SakaguchiMasa... | lld:pubmed |
pubmed-article:19885619 | pubmed:author | pubmed-author:OuchidaMamoru... | lld:pubmed |
pubmed-article:19885619 | pubmed:author | pubmed-author:ShimizuKenjiK | lld:pubmed |
pubmed-article:19885619 | pubmed:author | pubmed-author:KashiwakuraYu... | lld:pubmed |
pubmed-article:19885619 | pubmed:author | pubmed-author:KumonHiromiH | lld:pubmed |
pubmed-article:19885619 | pubmed:author | pubmed-author:NasuYasutomoY | lld:pubmed |
pubmed-article:19885619 | pubmed:author | pubmed-author:HuhNam-HoNH | lld:pubmed |
pubmed-article:19885619 | pubmed:author | pubmed-author:KakuHarukiH | lld:pubmed |
pubmed-article:19885619 | pubmed:author | pubmed-author:OchiaiKazuhik... | lld:pubmed |
pubmed-article:19885619 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19885619 | pubmed:volume | 24 | lld:pubmed |
pubmed-article:19885619 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19885619 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19885619 | pubmed:pagination | 789-94 | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:meshHeading | pubmed-meshheading:19885619... | lld:pubmed |
pubmed-article:19885619 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19885619 | pubmed:articleTitle | REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells. | lld:pubmed |
pubmed-article:19885619 | pubmed:affiliation | Department of Urology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan. | lld:pubmed |
pubmed-article:19885619 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19885619 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:50781 | entrezgene:pubmed | pubmed-article:19885619 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:19885619 | lld:entrezgene |